Similar articles

• Trimethoprim-sulphamethoxazole in the treatment of urinary infection.

  Brumfitt W, Pursell R. Brumfitt W, et al. Med J Aust. 1973 Jun 30;1(2):Suppl:44-8. doi: 10.5694/j.1326-5377.1973.tb111187.x. Med J Aust. 1973. PMID: 4580586 Clinical Trial. No abstract available.
• [Results of treatment with trimethoprim-sulfamethoxazole in nonspecific urinary tract infections in pediatric urology].

  Schach H, Scheidt J, Neussel H. Schach H, et al. Monatsschr Kinderheilkd (1902). 1972 Sep;120(9):346-9. Monatsschr Kinderheilkd (1902). 1972. PMID: 4563169 Clinical Trial. German. No abstract available.
• [Short-term therapy of urinary tract infections with a combination of trimethoprim and sulfamethoxazole].

  Prát V. Prát V. Cas Lek Cesk. 1971 Oct;110(43):1000-3. Cas Lek Cesk. 1971. PMID: 4939127 Czech. No abstract available.
• [Clinical experiences with the trimethoprim and sulfamethoxazole association in the treatment of chronic urinary tract infections].

  Urlesberger H, Henning K. Urlesberger H, et al. Wien Klin Wochenschr. 1970 Oct 5;82(40):699-702. Wien Klin Wochenschr. 1970. PMID: 5522092 German. No abstract available.
• Folate antagonists as antibacterial and antiprotozoal agents.

  Hitchings GH. Hitchings GH. Ann N Y Acad Sci. 1971 Nov 30;186:444-51. doi: 10.1111/j.1749-6632.1971.tb31171.x. Ann N Y Acad Sci. 1971. PMID: 5002439 Review. No abstract available.